Back

Relative effectiveness of high-dose vs. standard-dose quadrivalent influenza vaccine in chronic kidney disease: a secondary analysis of the DANFLU-1 trial

30 August 2024 (14:03 - 14:22)
Organised by: Logo
Congress Presentation Part of: Caring for kidney disease patients in a cardiology setting: what is important? Renal Failure and Cardiovascular Disease ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Katja Vu Bartholdy

Copenhagen University Hospital, Copenhagen (Denmark)

3 More presentations in this session

Presentation thumbnail
State-of-the-art lecture on caring for kidney disease patients in a cardiology setting: what is important?
Professor C. Wanner (Wuerzburg, DE)
Slides Video
Presentation thumbnail
Prognostic value of C-reactive protein / albumin ratio for amputation and/or mortality after lower extremity revascularization in haemodialysis patients with peripheral artery disease
Assistant Professor H. Takahashi (Toyoake, JP)
Abstract Slides Video
Presentation thumbnail
Association of a history of acute kidney injury with major adverse cardiovascular events in chronic kidney disease patients
Doctor B. Tyl (La Garenne Colombes Cedex, FR)
Abstract Slides Video

Access the full session

Session thumbnail
Caring for kidney disease patients in a cardiology setting: what is important?
Video

The Event

Event poster

ESC Congress 2024

30 August 2024 14:03 CET
You may be interested in
thumbnail
Congress Presentation
DANFLU-2: High-Dose vs. Standard-Dose Influenza Vaccine and Cardio-Respiratory Outcomes in Older Adults
thumbnail
Congress Session
Late-Breaking Clinical Trials: vaccinations in cardiovascular prevention
thumbnail
Congress Session
Caring for kidney disease patients in a cardiology setting: what is important?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources